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ABSTRACT 
Ectopic calcification is commonly associated with cardiovascular disease, injury, aging, and 
biomaterial implantation. We hypothesized that the normal mechanical environment of smooth 
muscle cells (SMCs) inhibits a phenotypic switch to a pattern of gene expression more typical 
for bone and inducive for calcification. This hypothesis was tested using a 3-D engineered 
smooth muscle tissue model subjected to cyclic mechanical strain. This simplified model 
maintained a 3-D tissue architecture while eliminating systemic effects as can be seen with in 
vivo models. All engineered tissues were found to express bone-associated genes (osteopontin, 
matrix gla protein, alkaline phosphatase, and the transcription factor CBFA-1). Strikingly, 
however, expression of these genes was down-regulated in tissues exposed to cyclic strain at all 
time points ranging from 5 to 150 days. Furthermore, long-term strain played a protective role in 
regard to calcification, as unstrained tissues exhibited increased calcium deposition with respect 
to strained tissues. The results of this study suggest that without an appropriate mechanical 
environment, SMCs in 3-D culture undergo a phenotypic conversion to an osteoblast-like pattern 
of gene expression. This finding has significant implications for the mechanisms underlying a 
variety of cardiovascular diseases and indicates the broad utility of engineered tissue models in 
basic biology studies. 
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E ctopic calcification, or calcium deposition in soft tissues, is a common problem associated with cardiovascular disease, many therapies used to treat cardiovascular disease (e.g., balloon angioplasty), and implantation of biomaterials (1, 2). Clinically, adverse effects of 
cardiovascular calcification include generally increased rigidity of tissues, rupture and dissection 
of tissues, and an increased risk of myocardial infarction (3). 
Several studies have implicated smooth muscle cells (SMCs) as one of the primary cell types 
associated with arterial calcification. These cells have the ability to calcify in culture (46), and a 
calcifying cell subpopulation derived from the aortic media has also been identified that exhibits 
osteoblastic characteristics (7). Recently, it has been shown that the process of arterial 
calcification is an active, cell-controlled event, much like the process of calcification in bone (1, 
3). The mechanisms regulating this process in smooth muscle remain unclear, but this process 
has been extensively studied in bone formation. Osteoblast differentiation occurs in several 
stages, involving the expression of various genes in each stage leading to mineralization (8). 
Proteins typically associated with bone formation appear to act as key mediators of calcification 
in the cardiovasculature as well. Molecular mediators of calcification in bone, including 
osteopontin (OPN) and its transcription factor core binding factor-1 (CBFA-1), matrix gla 
protein (MGP), and alkaline phosphatase, have been shown to be expressed by SMCs and 
associate with sites of calcification in vivo (9, 10) and in vitro (7, 1114). Interestingly, OPN 
expression by SMCs is elevated during neointima formation following aortic injury (9, 15), and 
aortic rings excised from rats and grown statically in culture showed increased amounts of OPN 
and MGP with time (11). 
It is likely that mechanical stimuli may mediate cardiovascular calcification. Mechanical strain is 
a strong regulator of SMC phenotype and is crucial for maintenance of SMCs in a differentiated 
state (16). SMCs in the cardiovascular system are constantly exposed to cyclic mechanical 
stretch and normally exist in a contractile, or differentiated, state. An altered mechanical 
environment causes these cells to revert to a synthetic phenotype, in which the cells lose their 
ability to contract and increase their proliferation, migration, and secretion of proteins (17). The 
altered mechanical environment resulting from atherosclerosis, vascular injury, and biomaterial 
implantation has been linked to SMC hypertrophy, hyperplasia, and migration. Strikingly, in 
bone and cultured bone cells, numerous studies have found that expression of genes associated 
with mineralization (e.g., OPN) and calcification itself is sensitive to the mechanical 
environment (1820). 
We hypothesize that the lack of an appropriate mechanical environment induces a phenotypic 
switch of cultured SMCs to a pattern of gene expression more typical for bone, leading to 
enhanced calcification. To address this hypothesis, a smooth muscle engineered tissue model was 
used in order to more closely mimic the natural 3-D architecture of smooth muscle in vivo than 
the typical 2-D systems used in in vitro studies. In this model, rat aortic SMCs were grown 
within type I collagen sponges. Rat SMCs were chosen to allow direct comparison with previous 
studies of the effect of cyclic strain on the maintenance of SMC phenotype in this system (21). 
This simplified system maintained a 3-D tissue architecture, while eliminating the complication 
of systemic effects that have been also shown to regulate biomineralization, such as macrophage 
infiltration and circulating factors (22). 
MATERIALS AND METHODS 
Isolation and culture of rat aortic SMCs 
SMCs were isolated from rat aortas by using an adaptation of a previously published technique 
(21). In brief, the descending aortas of 100- to 150-g adult male Lewis rats (Charles River 
Laboratories, Wilmington, MA), after the removal of endothelium, adventitia, fat, and 
connective tissue, were cut into multiple small pieces and incubated under agitation with an 
orbital shaker (60 rpm) for 90 min at 37°C in a sterile conical containing an enzymatic 
dissociation buffer. This buffer contained 0.125 mg/ml elastase (Sigma, St. Louis, MO), 1.0 
mg/ml collagenase (CLS type I, 204 U/mg, Worthington Biochemical, Freehold, NJ), 0.250 
mg/ml soybean trypsin inhibitor (type 1-S, Sigma), and 2.0 mg/ml crystallized bovine serum 
albumin (BSA; Gibco/Life Technologies, Gaithersburg, MD). Following the complete 
dissolution of the matrix, the resultant cell suspension was filtered through a 100-µm Nitex filter 
(Tetko, Briarcliff Manor, NY) and centrifuged at 200g for 5 min. The pellet was resuspended in 
growth medium consisting of Medium 199 (Gibco) supplemented with 20% fetal bovine serum 
(FBS; Gibco), 2 mM L-glutamine (Gibco), 100 U/ml penicillin (Gibco), and 0.1 mg/ml 
streptomycin (Gibco). Cells pooled from two to three aortas were seeded onto a tissue culture 
flask (25 cm2). SMCs were maintained in growth media containing 20% FBS until the first 
passage, whereas all subsequent cultures were grown in the presence of 10% FBS. SMCs 
between passage 6 and 15 were used in all experiments in this study. 
Cell seeding and application of mechanical strain 
For static, 2-D experiments, SMCs were seeded onto T25 flasks (1×104 cells/cm2) and grown for 
various times. Smooth muscle tissues were constructed by seeding cells onto 4×1 cm, 3.5-mm-
thick, type I collagen sponges (Integra Life Science, Plainsboro, NJ) at a density of 2.1×106 
cells/cm3. After seeding, all samples were cultured for 3 days in petri dishes and then placed in 
spinner flasks (working volume = 50 ml, Bellco Glass; 40 rpm) and cultured for 7 additional 
days, with the medium changed every other day. Before strain application, the medium was 
changed and supplemented with 50 µg/ml ascorbic acid. 
A custom-made mechanical strain device was used in these studies (Fig. 1). (21). With this 
device, sponges are held submersed in culture medium between two clamps. One clamp is 
moved back and forth by a crank attached to an eccentric disk, thereby applying strain to the 
substrate as the disk rotates. The entire device is maintained within an incubator during the 
course of experiments. The ability of this custom-made device to confer a uniform strain along 
the length of the substrate was assessed using a collagen sponge positioned within the device. 
Digital photographs (Sony, New York, NY) were taken initially and following the application of 
nominal strain of 7% of initial length. Images were analyzed in Adobe Photoshop (Adobe, San 
Jose, CA), and strain was calculated by measuring the relaxed (initial) and distended (final) 
lengths at distinct positions within a grid pattern (parallel and perpendicular to strain direction) 
superimposed on the sponge. 
Tissues receiving strain application were subjected to cyclic strain at a frequency of 1 Hz and an 
amplitude of 7%. Designated control tissues were fixed at only one end within this device and 
moved at the same frequency and amplitude in a second bioreactor. At the end of each 
experiment, tissues were rinsed in phosphate-buffered saline (PBS) and either snap frozen in 
liquid N2 and stored frozen (for RNA analysis), immersed in lysis buffer (see formulation below) 
(23) and stored frozen (for protein analysis), or fixed (for histological analysis). 
For strain application in 2-D studies, SMCs were seeded onto commercially available, flexible 
membranes (Bioflex; Flexcell Corp., McKeesport, PA) at 1×104 cells/cm2 and were subjected to 
cyclic strain using a Flexercell unit (Flexcell Corp.). Cell seeding was confined to an area of 5 
cm2 in the center of each well by using a Teflon ring weighted down by a washer in order to 
provide a uniform strain field to all cells. Bioflex plates were first exposed overnight to UV 
radiation from the sterilization bulb in a standard cell culture hood in order to activate the surface 
(24). Membranes were then precoated before seeding with type I collagen (Collaborative 
Biomedical Products, Bedford, MA) at a density of 2 µg/cm2 and then washed with PBS. Cells 
were allowed to adhere and spread for 24 h postseeding. Cells were subjected to cyclic strain at a 
frequency of 0.25 Hz (2 s strain, 2 s relaxation) and an amplitude of 7% for 2 days. At the end of 
each experiment, total RNA was isolated from cells by using Trizol and analyzed as described 
below. 
Northern blot analysis 
Total RNA from cells was isolated with Trizol (Life Technologies, Grand Island, NY) as per the 
manufacturers instructions. RNA was quantified by fluorimetry, using Sybr Green-2 dye 
(Molecular Probes, Eugene, OR), and 510 µg were separated in a 1.25% agarose, 2.2 M 
formaldehyde gel and transferred overnight to Hybond-N blotting membranes (Amersham, 
Arlington Heights., IL). The RNA was crosslinked to the membrane by exposure to a UV light 
source at 70,000 Joules/cm2 (UV Stratalinker 2400, Stratagene, La Jolla, CA). OPN (a generous 
gift from M. Somerman [25]), MGP, and CBFA-1 (both generous gifts from R. Franceschi [26]), 
and the housekeeping gene glyceraldehyde phosphate dehydrogenase (GAPDH) cDNA probes 
were randomly labeled with a 32P dCTP (Amersham). Membranes were sequentially hybridized 
using Rapid-hyb buffer (Amersham) at 65°C overnight. Membranes were washed progressively 
to high stringency (0.2× SSC, 0.1% SDS at 65°C) and autoradiographed (BioMax MS film, 
Kodak) at 70°C with an MS intensifying screen. Bands were quantified densitometrically by 
scanning films into Scion Image (NIH Image), and mRNA levels were normalized to GAPDH 
mRNA levels. Data from long-term experiments were pooled from three to five experiments 
ranging in length from 20 to 35 days in duration. 
Western blot analysis 
Proteins from engineered tissues were isolated by suspending each tissue in 250 µl lysis buffer 
(23) containing 25 mM Tris, pH 7.4, 0.4 M NaCl, 0.5% SDS with protease inhibitors (10 µg/ml 
aprotinin, 10 µg/ml leupeptin, 5 µg/ml pepstatin, and 0.5 M PMSF) and freezing. After thawing, 
tissues were crushed manually with a microfuge tube tissue pulverizer, vortexed, and 
centrifuged. Supernatants were analyzed for DNA by using Hoechst 33258 dye and a 
fluorometer (Hoefer DyNA Quant 200, Pharmacia Biotech, Uppsala, Sweden) (27). Protein 
samples representing equal amounts of DNA from each sample were mixed with Laemmli 
sample buffer (1:1, Bio-Rad, Hercules, CA), and proteins were separated by SDS-PAGE on 10
20% Tris-HCl reducing gels (Bio-Rad). Proteins were then transferred to polyvinylidene 
difluoride (PVDF) membranes (Bio-Rad). Membranes were blocked with 5% dried milk in TBS-
T (0.1% Tween-20 in TBS) for 1 h and probed with mouse anti-OPN antibody (MPIIIB10; 
Developmental Studies Hybridoma Bank, Iowa City, IA) diluted 1:50 with TBS-T for 1 h at 
25°C. Membranes were then washed and incubated with 1:1000 dilution of horseradish 
peroxidase-conjugated anti-mouse IgG (Bio-Rad) for 1 h. Detection was by chemiluminescence 
with an enhanced chemiluminescence kit (Amersham). Bands were quantified densitometrically 
by scanning films into Scion Image (NIH Image) and analyzed (n=3). 
Histological analysis 
For histological analysis, samples were fixed in Z-Fix (Anatech, Battle Creek, MI), paraffin 
embedded, sectioned, and stained with Gill 3 hematoxylin (Sigma) and eosin (Sigma). For 
immunostaining, sections were deparaffinized and washed for 5 min in 3% H2O2 (Sigma) to 
quench endogenous peroxidases. After incubating for 10 min with terminator blocking solution 
(Biocare Medical, Walnut Creek, CA) to prevent nonspecific antibody-antigen interactions, 
sections were allowed to incubate with antibodies to OPN (MPIIIB10), diluted 1:50, for 1 h at 
37°C. Biotinylated universal link (Biocare Medical) secondary antibody was used for 30 min 
followed by a 15-min incubation with streptavidin-HRP (Biocare Medical). The HRP reaction 
was completed with 3,3-diaminobenzidine (Zymed, South San Francisco, CA) for 10 min. Tissue 
sections were visualized using a Nikon Ellipse E800 microscope. 
Biochemical assays 
Alkaline phosphatase activity was measured from cell lysates using p-nitrophenyl phosphate 
substrate as described previously (28). Enzyme activity was normalized to total DNA in the 
tissue, determined by the Hoechst 33258 fluorescent dye binding assay (n=3). 
Calcification of tissues was assessed by a modification of the method described by Wada et al. 
(4). Tissues were rinsed thoroughly in PBS and exposed to lysis buffer as described previously. 
Supernatants were analyzed for DNA as described and calcium by the o-cresolphthalein 
complexone method (Calcium Kit, Sigma). The remaining solids were minced and decalcified 
with 0.6 N HCl for 24 h. The HCl supernatant was assayed for calcium as well. Calcium content 
from the lysate (cell-associated, soluble calcium) and HCl (matrix-associated, deposited calcium) 
supernatants was added together, and values were normalized to total DNA content in the tissues 
(n=3). 
Statistical analysis 
Data were expressed as the means ±SD. Statistical comparisons were performed using unpaired 
Students t test (InStat, GraphPad Software). A value of P<0.05 was considered to be statistically 
significant unless otherwise noted. 
RESULTS 
To confirm that rat aortic SMCs express OPN, we isolated total RNA from cells following 
culture on standard tissue culture flasks for varying time periods. As expected, OPN mRNA 
levels increased over time in cultured cells (Fig. 2). However, 2-D cell culture is a poor 
representation of the natural tissue environment of SMCs, which is 3-D, is mechanically 
dynamic, and involves the interaction of multiple cell types. To determine whether up-regulation 
of OPN resulted solely from the 2-D culture conditions, smooth muscle tissues were engineered 
to mimic the 3-D aspect of the normal environment by seeding and culturing SMCs in type I 
collagen sponges (Fig. 3a and 3c). Cells within the tissues adhered, proliferated, and produced 
their own ECM to form 3-D tissues (Fig. 3b and 3d). Immunohistochemical analysis revealed 
significant OPN deposition around cells within engineered tissues (Fig. 3e and 3f), and OPN 
expression increased with time in a similar manner (Fig. 3g) as observed in 2-D culture. 
The role of mechanical stimulation on OPN expression by SMCs in the engineered tissues was 
investigated by exposing tissues to cyclic mechanical strain (7%, 1 Hz) in a custom-made 
bioreactor. To ensure that the strain being applied to the clamped substrate was uniform along its 
entire length, the mechanical strain device was first characterized. A collagen sponge was 
positioned within the device, and the strain was quantified within a grid pattern of nine regions 
superimposed on the sponge (three lines parallel to strain direction, three lines perpendicular to 
strain direction). Measurements of the strain at each point parallel to the strain direction revealed 
a consistent amount of strain along the length of the membrane (Fig. 4). However, a gradient of 
strain was apparent in the perpendicular axis, with maximal strain occurring in the middle of the 
sponge, along the outer regions. Previous studies have demonstrated that the collagen sponges 
used in these experiments exhibit little permanent deformation with this pattern of constant 
repeated strain application (29). 
OPN protein within engineered tissues was first analyzed after 15 days in culture, using Western 
analysis of tissue lysates. Quantification of triplicate samples over multiple experiments revealed 
a 2.2-fold decrease in OPN protein deposited in strained as compared with nonstrained tissues 
(Fig. 5). To confirm the mechanical responsiveness of OPN expression in SMCs, similar studies 
measuring OPN levels were performed with mRNA isolated from 2-D cultures of cells adherent 
to an elastic membrane and cyclically strained. The short-term (2-day) response of cells in this 
system revealed a similar expression pattern for OPN (data not shown) to that observed in the 3-
D system. However, the effect of strain on long-term cell phenotype in this system could not be 
ascertained, because cell sheets began to detach from membranes beyond 1 wk of culture. 
Experiments were next performed to determine whether strain regulated a larger-scale 
phenotypic change of SMCs to a bonelike pattern of gene expression in the engineered tissues. 
OPN mRNA expression in control tissues (maintained in bioreactor with no strain application) 
increased over time (Fig. 6a), as noted in standard culture conditions (Fig. 3g). However, tissues 
exposed to chronic strain maintained low and fairly constant OPN levels, leading to unstrained 
tissues expressing between 2.7 and 4.1 times the OPN mRNA amounts of strained tissues after 5 
wk and 5 months, respectively (Fig. 6a). A small, but reproducible increase in mRNA levels in 
strained vs. control tissues was found, however, at the earliest time point (2 days). A panel of 
genes typically recognized as markers for osteoblast differentiation was also studied. mRNA 
levels of CBFA-1, a transcription factor controlling OPN expression and normally associated 
with osteoblast differentiation, were quantified in strained vs. nonstrained engineered tissues. 
CBFA-1 mRNA levels followed a similar temporal profile as OPN, as expected for a 
transcription factor and the gene it regulates. Strained tissues maintained fairly constant mRNA 
levels over time, but unstrained tissues exhibited higher message levels for the 5-wk duration of 
the experiment (Fig. 6b). We then investigated the expression of MGP, another protein 
implicated in the calcification process. Expression of MGP followed a similar pattern to that of 
OPN, as levels were up-regulated over time in culture in control tissues, and this effect was again 
largely eliminated with application of cyclic strain (Fig. 6c). To determine the reproducibility of 
these results, we pooled the effect of cyclic strain on long-term levels of OPN, MGP, and CBFA-
1 mRNA in multiple experiments, and levels for all three genes were found to be significantly 
lower than control/unstrained tissues. Message levels for OPN, MGP, and CBFA-1 in strained 
tissues decreased by 2.1, 1.7, and 2.0 times, respectively, as compared with control tissues (Fig. 
6d). 
Finally, engineered tissues were analyzed to determine whether the noted changes in gene 
expression were paralleled by changes in cell phenotype leading to mineralization. The activity 
of alkaline phosphatase, an enzyme involved in mineral formation and an established osteoblast 
differentiation marker, was determined in strained vs. unstrained engineered tissues. There were 
no differences between strained and control tissues at the initial time points analyzed, but at 5 
wk, the alkaline phosphatase activity in control tissues was more than 3.5 times greater than in 
tissues exposed to cyclic strain (Fig. 7a). Not surprisingly, the changes in SMC phenotype 
resulting from long-term cyclic strain led to significant variations in the total calcium deposited 
within tissues. Exposure to strain for 5 wk caused a significant decrease in the amount of calcium 
deposited in strained tissues, as compared with control tissues (Fig. 7b). 
DISCUSSION 
Vascular calcification is a common health problem and is thought to be an actively regulated 
process similar to osteogenesis. Mechanical stresses and strains are clearly significant 
extracellular stimuli that regulate the phenotype of vascular SMCs and play an important role in 
the development of hypertension and atherosclerosis (30). Although mechanical strain has been 
associated with these disease processes, there is little previous evidence implicating strain in 
modulating the calcification process regulated by SMCs. As demonstrated in these studies, cyclic 
mechanical strain inhibits a phenotypic switch of SMCs to a pattern of gene expression more 
typical for bone, and thus relevant to calcification. A 3-D smooth muscle tissue model system 
composed of SMCs grown within type I collagen sponges revealed that the expression of a 
variety of markers implicated with various stages of bone differentiation and calcification (OPN, 
CBFA-1, MGP, alkaline phosphatase) was found to be up-regulated over time in static culture. In 
addition, not only were these markers responsive to mechanical stimuli, but chronic stimulation 
was found to down-regulate the expression of these bone-associated genes and play a protective 
role in calcification. These data suggest that cyclic mechanical strain is an important signal 
inhibiting the expression of genes associated with calcification. 
SMCs grown in static culture were found to up-regulate the expression of markers associated 
with bone differentiation over time. Cells cultured statically in two-dimensions, as well as within 
a 3-D engineered tissue, exhibited an increase in early markers of bone differentiation (e.g., 
CBFA-1, a transcription factor normally associated with the differentiation of osteoblasts), as 
well as markers associated with bone matrix maturation (e.g., alkaline phosphatase, OPN, and 
MGP). The observation that these genes are expressed by vascular cells is not a new one, as 
recent evidence has implicated a similar phenotypic transition associated with calcification 
within SMC cultures, noted by increases in CBFA-1, OPN, osteocalcin, and alkaline phosphatase 
and decreases in smooth muscle lineage markers SM22 and α-smooth muscle actin (2, 13). 
Similarly, a calcifying cell line has been isolated from aortas expressing OPN, alkaline 
phosphatase, and bone morphogenetic protein-2, further providing proof for the existence of cells 
demonstrating a bonelike phenotype within the vasculature (31). 
The studies outlined here are, however, the first to demonstrate the modulation of expression of 
these bone-associated proteins in smooth muscle by long-term application of strain. In agreement 
with the finding that cyclic mechanical strain suppresses bone-associated gene expression, strain 
was also found to play a protective role in calcification in this system. This effect was found 
even though cells were cultured under normal, noncalcification-inducing conditions (e.g., no 
addition of calcification agents such as β-glycerolphosphate). Several previous studies clearly 
document that application of strain can have significant effects on SMC phenotype (e.g., cell 
alignment, protease expression) in engineered tissues (32, 33) but have not examined the 
expression of bone-associated genes. Our findings with OPN are supported by a previous study 
demonstrating that short-term pressure modulates expression of OPN in cultured human aortic 
SMCs (34). Similarly, following the removal of mechanical stimulus, an up-regulation of OPN 
and MGP was demonstrated over time when aortic rings were excised from rats and grown in 
static culture (11). The relevance of a mechanically controlled SMC phenotype switch, as 
demonstrated in this study, is also supported by previous findings that demonstrate an up-
regulation of bone-associated genes in the neointima of injured or atherosclerotic arteries (9, 15) 
or in other situations that result in an altered mechanical environment of SMCs (3). 
The effects of mechanical signals on SMC and smooth muscle tissue function are likely complex 
and dependent on the specific mechanical signal received by the cells. Previous studies clearly 
suggest that cyclic strain, in contrast to static strain, plays a significant role in the phenotypic 
modulation of SMCs from the synthetic to the contractile state (35) and in protein kinase A and 
C signaling (36). In support of these findings, we have previously documented that focal 
adhesion and cytoskeletal changes induced within rat SMCs by strain application are distinct for 
static vs. cyclic strain (37, 38). For example, recruitment of vinculin and paxillin to SMC focal 
adhesions occurs only following a minimum number of strain cycles, and not with a static stretch 
(38). The importance of an appropriate strain regime has also been demonstrated with cultured 
chondrocytes and bone cells (3941). These findings may be related to a cells ability to 
rearrange their adhesions to find a lower stress state when subjected to a static strain, thus 
relieving the imposed load. The exact strain sustained by cells is likely affected by several 
factors, including the microstructure of the matrix to which they are adherent and matrix fiber 
orientation. Previous studies with a simple 2-D strain system have documented the transferal of 
strain to SMCs adherent to elastic membranes (37). Extending these studies to include the 
complexity of a 3-D environment and the effects of cyclic strain remain a challenge. Also note 
that SMCs in vivo typically experience a complex strain environment that is not fully replicated 
by the relatively simple strain pattern used in the current study. 
In contrast to the chronic effects of cyclic strain, a small but reproducible up-regulation of both 
OPN and CBFA-1 gene expression was noted following 2 days of strain. The parallel expression 
profiles of OPN and CBFA-1 in both short- and long-term responses is not surprising, because 
CBFA-1 has been shown to regulate the expression of OPN (26, 42). We speculate that the short-
term up-regulation of these genes is due to an injury response by the cells, because they may 
interpret the onset of strain as an injury due to their maintenance in static culture before the start 
of these experiments. It has been previously reported that OPN delivers a receptor-mediated 
prosurvival, antiapoptotic signal to cells following injury (43) and may provide pro- and 
antiinflammatory effects in vivo. 
The use of a tissue-engineered, 3-D model holds great promise as a tool with which to study 
vascular biology and disease. SMCs maintained in more typical 2-D culture detached from the 
culture surface with long-term application of continuous cyclic strain, precluding the use of that 
system in the experiments performed in the current study. Furthermore, the tissue model used in 
this study has been previously characterized to exhibit a similar ECM composition (e.g., collagen 
and elastin content) and SMC density as native smooth muscle tissue (27, 44). The application of 
cyclic strain was found to alter matrix synthesis and lead to enhanced alignment of matrix and 
cells in the tissues (21). The cell response to cyclic strain observed in the current study is likely 
mediated by the type and organization of this cell-assembled matrix. Tissue-engineered 
cardiovascular model systems have also been used to study the pharmacological effects of 
various drugs (45), ECM production and turnover within blood vessels (32, 46), and the effect of 
matrix structure on cell alignment (33) and have shown utility in vivo as potential replacement 
tissues (47, 48). One limitation to the use of these systems for in vitro studies is the lack of 
vascularization and resulting loss of viability of cells in the interior of these tissues. This was 
observed in the present study; viable SMCs were present only in the exterior regions of the 
engineered tissues. However, various bioreactor systems have been developed to alleviate the 
transport limitations inherent to static in vitro culture systems and allow for thicker tissues to be 
grown in vitro (49, 50). In any case, engineered tissue systems allow the replication of particular 
aspects of native tissue, such as their 3-D architecture and the presence of mechanical signals. 
The versatility of this model system also potentially allows for other complexities of the vascular 
environment, such as the presence of different cell types (e.g., fibroblasts, endothelial cells, 
macrophages) or the involvement of circulating cytokines, to be examined in a controlled 
manner. 
Altogether, the results of this study lead to a model outlining the effects of mechanical strain on 
SMC phenotype that suggests SMCs undergo a phenotypic conversion to a more osteoblast-like 
pattern of gene expression without an appropriate mechanical signal (e.g., exposure to cyclic 
mechanical strain) (Fig. 8). However, exposure to strain maintains the SMC phenotype, as 
supported by past findings of enhanced cell and matrix organization, increased tissue mechanical 
properties, and increased myofilament bundles in these engineered smooth muscle tissues (21). 
In contrast to bone, in which mechanical stimuli have been shown to enhance mineral deposition 
(51), mechanical strain within this smooth muscle model system had an inhibitory effect on 
mineralization. Normally within the cardiovasculature, smooth muscle tissues are constantly 
exposed to mechanical strain due to vessel wall distension. It is hypothesized that a disruption of 
the normal vessel architecture and thus normal mechanical environment, which occurs with 
disease or balloon angioplasty, could be one mechanism responsible for the calcification seen 
with these conditions. This model may generally aid in interpreting and preventing the 
calcification of vascular tissues commonly observed in various pathologic and therapeutic 
situations in which the mechanical environment of the tissue is altered. Furthermore, these data 
provide support to the plasticity of the smooth muscle phenotype and its regulation by 
environmental factors such as mechanical strain. Finally, this report indicates the utility of 
engineered tissues for basic biology studies, because the desired features of normal tissues (e.g., 
3-D architecture) can be controllably built into a highly defined model system. 
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Figure 1. Tissue strain device. Engineered tissues were strained in a custom-made device. Samples were held between 
clamps (arrowheads), and one clamp was moved back and forth by a motorized eccentric disk, applying strain onto the 
sample (moving parts are indicated with arrows, along with direction of movement). Frequency was controlled using a 




          
 
Figure 2. Smooth muscle cells increase expression of osteopontin over time in static culture. A) Northern blot 
showing osteopontin and the housekeeping gene glyceraldehyde phosphate dehydrogenase (GAPDH) mRNA bands from 
smooth muscle cells over time following plating onto polystyrene tissue culture dishes. B) Message levels were quantified 






Figure 3. Osteopontin expression in engineered smooth muscle tissues.  Scanning electron micrographs of collagen 
sponges (A) and sponges with adherent smooth muscle cells 3 days after cell seeding (B). Hematoxylin and eosin-stained 
sections of collagen sponges alone (C), and engineered smooth muscle tissues 23 days after seeding (D). Tissues grown for 
5 wk under static culture expressed osteopontin as shown by immunohistochemical analysis (E), as compared with controls 
to which no primary antibody was added (F) (micrographs at 200× magnification, insets at 1000×). Osteopontin mRNA 




                        
Figure 4. Strain profile in sponges. The strain profile in collagen sponges subjected to 7% strain by the custom device 
was evaluated in multiple regions, where region A was 1 cm from the stationary clamp, region B was in the middle, and 
region C was 3 cm from the stationary clamp. Substrate strain was evaluated at each point in both the parallel (black bars) 





         
                        
Figure 5. Chronic cyclic strain down-regulates osteopontin in smooth muscle tissues. Representative Western blot  
(A) showing decreased amounts of osteopontin protein in tissues subjected to 15 days of cyclic strain, as compared with 





         
                        
Figure 6. Chronic cyclic strain down-regulates bone-specific genes in smooth muscle tissues.  Representative 
experiments showing osteopontin (OPN) (A), CBFA-1 (B), and matrix gla protein (MGP) (C) mRNA expression over time 
in smooth muscle tissues engineered with (dashed lines) or without (solid lines) exposure to cyclic strain. Northern blot 
analyses from multiple experiments run from 20 to 35 days were pooled, and values for mRNA levels are represented 





                  
                        
Figure 7. Long-term cyclic strain down-regulates mineralization markers in smooth muscle tissues. Quantification 
of alkaline phosphatase activity (A) and total calcium (B) in smooth muscle tissues engineered with (dashed lines) or 
without (solid lines) exposure to cyclic strain. Values represent mean (n=3) and standard deviation. *P<0.05 as compared 




              
                        
Figure 8. Proposed model of the effect of long-term cyclic mechanical strain on the phenotype of smooth muscle 
cells.  Cultured smooth muscle cells normally exist in the synthetic phenotype. Previous studies have demonstrated that 
exposing cells in engineered tissues to appropriate mechanical strain conditions converts the cells to a more differentiated 
phenotype, indicated by increased expression of myofilament bundles and increased cellular alignment. The current study 
demonstrates that tissues grown without the influence of strain increase their expression of genes indicative of an 
osteoblast phenotype and calcify to a greater extent. 
 
